{"entity":{"type":"insider","cik":"0001744884","url":"/insider/0001744884","json_url":"/insider/0001744884.json","name":"Shah Pritesh","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":79,"n_filings":45,"first":"2018-12-13","last":"2023-11-08","span_basis":"filed_date"},"name_variants":[{"name":"Shah Pritesh","source":"filing","n_filings":45,"first_seen":"2018-12-13","last_seen":"2023-11-08"}],"transactions":[{"id":8084637,"accession":"0001562180-23-007594","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-007594","line_url":"/filing/0001562180-23-007594#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Growth Officer)","role_mark":"O","role_mark_label":"Officer (Chief Growth Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Growth Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":382.0,"shares_display":"382","price_per_share":12.65,"price_display":"12.65","price_state":"stated","total_value":4832.3,"total_display":"4,832.30","total_whole":"4,832","shares_owned_after":124511.0,"shares_owned_after_display":"124,511","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-07","filed_date":"2023-11-08","scope":"insider"},{"id":7978244,"accession":"0001562180-23-006680","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-006680","line_url":"/filing/0001562180-23-006680#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Growth Officer)","role_mark":"O","role_mark_label":"Officer (Chief Growth Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Growth Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":273.0,"shares_display":"273","price_per_share":21.8172,"price_display":"21.82","price_state":"stated","total_value":5956.0956,"total_display":"5,956.10","total_whole":"5,956","shares_owned_after":124893.0,"shares_owned_after_display":"124,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-01","filed_date":"2023-09-05","scope":"insider"},{"id":8038769,"accession":"0001562180-23-002580","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-23-002580","line_url":"/filing/0001562180-23-002580","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Growth Officer)","role_mark":"O","role_mark_label":"Officer (Chief Growth Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Growth Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21421.0,"shares_display":"21,421","price_per_share":76.1594,"price_display":"76.16","price_state":"stated","total_value":1631410.5074,"total_display":"1,631,410.51","total_whole":"1,631,411","shares_owned_after":124799.0,"shares_owned_after_display":"124,799","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-03","filed_date":"2023-03-07","scope":"insider","n_lines":3},{"id":8655845,"accession":"0001562180-23-002492","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-23-002492","line_url":"/filing/0001562180-23-002492#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Growth Officer)","role_mark":"O","role_mark_label":"Officer (Chief Growth Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Growth Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":937.0,"shares_display":"937","price_per_share":75.2779,"price_display":"75.28","price_state":"stated","total_value":70535.3923,"total_display":"70,535.39","total_whole":"70,535","shares_owned_after":99038.0,"shares_owned_after_display":"99,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-02","filed_date":"2023-03-06","scope":"insider"},{"id":8661862,"accession":"0001645113-23-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-23-000030","line_url":"/filing/0001645113-23-000030#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Growth Officer)","role_mark":"O","role_mark_label":"Officer (Chief Growth Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Growth Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1923.0,"shares_display":"1,923","price_per_share":76.3624,"price_display":"76.36","price_state":"stated","total_value":146844.8952,"total_display":"146,844.90","total_whole":"146,845","shares_owned_after":99975.0,"shares_owned_after_display":"99,975","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-01","filed_date":"2023-03-02","scope":"insider"},{"id":8690697,"accession":"0001645113-23-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-23-000008","line_url":"/filing/0001645113-23-000008#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":387.0,"shares_display":"387","price_per_share":108.0,"price_display":"108.00","price_state":"stated","total_value":41796.0,"total_display":"41,796.00","total_whole":"41,796","shares_owned_after":82843.0,"shares_owned_after_display":"82,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-09","scope":"insider"},{"id":6635587,"accession":"0001645113-22-000075","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000075","line_url":"/filing/0001645113-22-000075#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":269.0,"shares_display":"269","price_per_share":79.037,"price_display":"79.04","price_state":"stated","total_value":21260.953,"total_display":"21,260.95","total_whole":"21,261","shares_owned_after":83230.0,"shares_owned_after_display":"83,230","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-02","filed_date":"2022-09-06","scope":"insider"},{"id":6402058,"accession":"0001645113-22-000031","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-22-000031","line_url":"/filing/0001645113-22-000031#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3669.0,"shares_display":"3,669","price_per_share":71.19,"price_display":"71.19","price_state":"stated","total_value":261196.11,"total_display":"261,196.11","total_whole":"261,196","shares_owned_after":83187.0,"shares_owned_after_display":"83,187","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-09","filed_date":"2022-03-11","scope":"insider"},{"id":6981250,"accession":"0001645113-22-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-22-000030","line_url":"/filing/0001645113-22-000030#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2481.0,"shares_display":"2,481","price_per_share":70.1,"price_display":"70.10","price_state":"stated","total_value":173918.1,"total_display":"173,918.10","total_whole":"173,918","shares_owned_after":81908.0,"shares_owned_after_display":"81,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-08","filed_date":"2022-03-09","scope":"insider"},{"id":6981247,"accession":"0001645113-22-000030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-22-000030","line_url":"/filing/0001645113-22-000030#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5294.0,"shares_display":"5,294","price_per_share":69.55,"price_display":"69.55","price_state":"stated","total_value":368197.7,"total_display":"368,197.70","total_whole":"368,198","shares_owned_after":84389.0,"shares_owned_after_display":"84,389","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-09","scope":"insider"},{"id":6103965,"accession":"0001645113-22-000020","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001645113-22-000020","line_url":"/filing/0001645113-22-000020","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4546.0,"shares_display":"4,546","price_per_share":72.10512054553453,"price_display":"72.11","price_state":"stated","total_value":327789.878,"total_display":"327,789.88","total_whole":"327,790","shares_owned_after":91597.0,"shares_owned_after_display":"91,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-04","filed_date":"2022-03-07","scope":"insider","n_lines":2},{"id":6103959,"accession":"0001645113-22-000020","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-22-000020","line_url":"/filing/0001645113-22-000020#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":997.0,"shares_display":"997","price_per_share":74.498,"price_display":"74.50","price_state":"stated","total_value":74274.506,"total_display":"74,274.51","total_whole":"74,275","shares_owned_after":94229.0,"shares_owned_after_display":"94,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-03","filed_date":"2022-03-07","scope":"insider"},{"id":5443897,"accession":"0001645113-21-000106","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001645113-21-000106","line_url":"/filing/0001645113-21-000106","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":501.0,"shares_display":"501","price_per_share":138.6761137724551,"price_display":"138.68","price_state":"stated","total_value":69476.733,"total_display":"69,476.73","total_whole":"69,477","shares_owned_after":73692.0,"shares_owned_after_display":"73,692","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-03","filed_date":"2021-09-07","scope":"insider","n_lines":3},{"id":5443886,"accession":"0001645113-21-000106","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000106","line_url":"/filing/0001645113-21-000106#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":156.0,"shares_display":"156","price_per_share":138.232,"price_display":"138.23","price_state":"stated","total_value":21564.192,"total_display":"21,564.19","total_whole":"21,564","shares_owned_after":74013.0,"shares_owned_after_display":"74,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-02","filed_date":"2021-09-07","scope":"insider"},{"id":5533354,"accession":"0001645113-21-000100","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000100","line_url":"/filing/0001645113-21-000100#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2063.0,"shares_display":"2,063","price_per_share":148.71,"price_display":"148.71","price_state":"stated","total_value":306788.73,"total_display":"306,788.73","total_whole":"306,789","shares_owned_after":74169.0,"shares_owned_after_display":"74,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-04","filed_date":"2021-08-06","scope":"insider"},{"id":5339902,"accession":"0001645113-21-000097","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000097","line_url":"/filing/0001645113-21-000097#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1654.0,"shares_display":"1,654","price_per_share":149.43,"price_display":"149.43","price_state":"stated","total_value":247157.22,"total_display":"247,157.22","total_whole":"247,157","shares_owned_after":76232.0,"shares_owned_after_display":"76,232","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-03","filed_date":"2021-08-04","scope":"insider"},{"id":4533277,"accession":"0001645113-21-000080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000080","line_url":"/filing/0001645113-21-000080#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23540.0,"shares_display":"23,540","price_per_share":215.0,"price_display":"215.00","price_state":"stated","total_value":5061100.0,"total_display":"5,061,100.00","total_whole":"5,061,100","shares_owned_after":77732.0,"shares_owned_after_display":"77,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-11","scope":"insider"},{"id":4702040,"accession":"0001645113-21-000065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000065","line_url":"/filing/0001645113-21-000065#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1290.0,"shares_display":"1,290","price_per_share":199.67,"price_display":"199.67","price_state":"stated","total_value":257574.3,"total_display":"257,574.30","total_whole":"257,574","shares_owned_after":101272.0,"shares_owned_after_display":"101,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-05","filed_date":"2021-05-06","scope":"insider"},{"id":5383131,"accession":"0001645113-21-000063","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000063","line_url":"/filing/0001645113-21-000063#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1043.0,"shares_display":"1,043","price_per_share":200.856,"price_display":"200.86","price_state":"stated","total_value":209492.808,"total_display":"209,492.81","total_whole":"209,493","shares_owned_after":102562.0,"shares_owned_after_display":"102,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-04","filed_date":"2021-05-05","scope":"insider"},{"id":4244348,"accession":"0001645113-21-000047","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000047","line_url":"/filing/0001645113-21-000047#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3524.0,"shares_display":"3,524","price_per_share":131.09,"price_display":"131.09","price_state":"stated","total_value":461961.16,"total_display":"461,961.16","total_whole":"461,961","shares_owned_after":101272.0,"shares_owned_after_display":"101,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-09","filed_date":"2021-03-10","scope":"insider"},{"id":4244344,"accession":"0001645113-21-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000047","line_url":"/filing/0001645113-21-000047#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2627.0,"shares_display":"2,627","price_per_share":130.806,"price_display":"130.81","price_state":"stated","total_value":343627.362,"total_display":"343,627.36","total_whole":"343,627","shares_owned_after":104796.0,"shares_owned_after_display":"104,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-08","filed_date":"2021-03-10","scope":"insider"},{"id":5080066,"accession":"0001645113-21-000042","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000042","line_url":"/filing/0001645113-21-000042#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4550.0,"shares_display":"4,550","price_per_share":131.53,"price_display":"131.53","price_state":"stated","total_value":598461.5,"total_display":"598,461.50","total_whole":"598,462","shares_owned_after":107423.0,"shares_owned_after_display":"107,423","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-05","filed_date":"2021-03-09","scope":"insider"},{"id":4578858,"accession":"0001645113-21-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000035","line_url":"/filing/0001645113-21-000035#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2658.0,"shares_display":"2,658","price_per_share":137.554,"price_display":"137.55","price_state":"stated","total_value":365618.532,"total_display":"365,618.53","total_whole":"365,619","shares_owned_after":97986.0,"shares_owned_after_display":"97,986","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-04","filed_date":"2021-03-05","scope":"insider"},{"id":4578853,"accession":"0001645113-21-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-21-000035","line_url":"/filing/0001645113-21-000035#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2174.0,"shares_display":"2,174","price_per_share":150.78,"price_display":"150.78","price_state":"stated","total_value":327795.72,"total_display":"327,795.72","total_whole":"327,796","shares_owned_after":100644.0,"shares_owned_after_display":"100,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-03","filed_date":"2021-03-05","scope":"insider"},{"id":5383128,"accession":"0001645113-21-000027","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-21-000027","line_url":"/filing/0001645113-21-000027#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":912.0,"shares_display":"912","price_per_share":152.053,"price_display":"152.05","price_state":"stated","total_value":138672.336,"total_display":"138,672.34","total_whole":"138,672","shares_owned_after":91932.0,"shares_owned_after_display":"91,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-02","filed_date":"2021-03-04","scope":"insider"},{"id":2117745,"accession":"0001645113-20-000135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-20-000135","line_url":"/filing/0001645113-20-000135","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28321.0,"shares_display":"28,321","price_per_share":85.4094320327672,"price_display":"85.41","price_state":"stated","total_value":2418880.5246,"total_display":"2,418,880.52","total_whole":"2,418,881","shares_owned_after":71165.0,"shares_owned_after_display":"71,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-11","scope":"insider","n_lines":2},{"id":9294055,"accession":"0001645113-20-000133","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-20-000133","line_url":"/filing/0001645113-20-000133#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4200.0,"shares_display":"4,200","price_per_share":85.0129,"price_display":"85.01","price_state":"stated","total_value":357054.18,"total_display":"357,054.18","total_whole":"357,054","shares_owned_after":98786.0,"shares_owned_after_display":"98,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-02","filed_date":"2020-09-11","scope":"insider"},{"id":2189030,"accession":"0001645113-20-000124","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-20-000124","line_url":"/filing/0001645113-20-000124#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4200.0,"shares_display":"4,200","price_per_share":85.0129,"price_display":"85.01","price_state":"stated","total_value":357054.18,"total_display":"357,054.18","total_whole":"357,054","shares_owned_after":98786.0,"shares_owned_after_display":"98,786","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-02","filed_date":"2020-09-03","scope":"insider"},{"id":3266965,"accession":"0001645113-20-000116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-20-000116","line_url":"/filing/0001645113-20-000116#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2048.0,"shares_display":"2,048","price_per_share":76.81,"price_display":"76.81","price_state":"stated","total_value":157306.88,"total_display":"157,306.88","total_whole":"157,307","shares_owned_after":101018.0,"shares_owned_after_display":"101,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-04","filed_date":"2020-08-05","scope":"insider"},{"id":3266960,"accession":"0001645113-20-000116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-20-000116","line_url":"/filing/0001645113-20-000116#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1669.0,"shares_display":"1,669","price_per_share":76.406,"price_display":"76.41","price_state":"stated","total_value":127521.614,"total_display":"127,521.61","total_whole":"127,522","shares_owned_after":103066.0,"shares_owned_after_display":"103,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"},{"id":2548701,"accession":"0001645113-20-000072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-20-000072","line_url":"/filing/0001645113-20-000072#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1149.0,"shares_display":"1,149","price_per_share":62.2,"price_display":"62.20","price_state":"stated","total_value":71467.8,"total_display":"71,467.80","total_whole":"71,468","shares_owned_after":100693.0,"shares_owned_after_display":"100,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-05","filed_date":"2020-05-07","scope":"insider"},{"id":2835532,"accession":"0001645113-20-000069","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-20-000069","line_url":"/filing/0001645113-20-000069#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1184.0,"shares_display":"1,184","price_per_share":60.079,"price_display":"60.08","price_state":"stated","total_value":71133.536,"total_display":"71,133.54","total_whole":"71,134","shares_owned_after":101842.0,"shares_owned_after_display":"101,842","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-04","filed_date":"2020-05-05","scope":"insider"},{"id":2189013,"accession":"0001645113-20-000049","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001645113-20-000049","line_url":"/filing/0001645113-20-000049","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Restricted Share Units","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6151.0,"shares_display":"6,151","price_per_share":66.75694261095757,"price_display":"66.76","price_state":"stated","total_value":410621.954,"total_display":"410,621.95","total_whole":"410,622","shares_owned_after":100693.0,"shares_owned_after_display":"100,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-06","filed_date":"2020-03-10","scope":"insider","n_lines":2},{"id":2933375,"accession":"0001645113-20-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-20-000037","line_url":"/filing/0001645113-20-000037#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1485.0,"shares_display":"1,485","price_per_share":72.97,"price_display":"72.97","price_state":"stated","total_value":108360.45,"total_display":"108,360.45","total_whole":"108,360","shares_owned_after":67721.0,"shares_owned_after_display":"67,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-05","scope":"insider"},{"id":2654078,"accession":"0001645113-20-000035","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001645113-20-000035","line_url":"/filing/0001645113-20-000035#line-2","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1601.0,"shares_display":"1,601","price_per_share":72.215,"price_display":"72.22","price_state":"stated","total_value":115616.215,"total_display":"115,616.22","total_whole":"115,616","shares_owned_after":69206.0,"shares_owned_after_display":"69,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-28","filed_date":"2020-03-02","scope":"insider"},{"id":2188999,"accession":"0001645113-20-000026","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001645113-20-000026","line_url":"/filing/0001645113-20-000026","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7932.0,"shares_display":"7,932","price_per_share":79.39049016641452,"price_display":"79.39","price_state":"stated","total_value":629725.368,"total_display":"629,725.37","total_whole":"629,725","shares_owned_after":69221.0,"shares_owned_after_display":"69,221","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-26","filed_date":"2020-02-28","scope":"insider","n_lines":3},{"id":2188990,"accession":"0001645113-20-000026","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001645113-20-000026","line_url":"/filing/0001645113-20-000026#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5067.0,"shares_display":"5,067","price_per_share":81.156,"price_display":"81.16","price_state":"stated","total_value":411217.452,"total_display":"411,217.45","total_whole":"411,217","shares_owned_after":75653.0,"shares_owned_after_display":"75,653","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-25","filed_date":"2020-02-28","scope":"insider"},{"id":7884085,"accession":"0001209191-19-044836","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-044836","line_url":"/filing/0001209191-19-044836#line-1","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1813.0,"shares_display":"1,813","price_per_share":85.23,"price_display":"85.23","price_state":"stated","total_value":154521.99,"total_display":"154,521.99","total_whole":"154,522","shares_owned_after":76976.0,"shares_owned_after_display":"76,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-02","filed_date":"2019-08-06","scope":"insider"},{"id":8239989,"accession":"0001209191-19-044234","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-044234","line_url":"/filing/0001209191-19-044234#line-4","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1905.0,"shares_display":"1,905","price_per_share":83.203,"price_display":"83.20","price_state":"stated","total_value":158501.715,"total_display":"158,501.72","total_whole":"158,502","shares_owned_after":78789.0,"shares_owned_after_display":"78,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-01","filed_date":"2019-08-02","scope":"insider"},{"id":8239985,"accession":"0001209191-19-044234","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-044234","line_url":"/filing/0001209191-19-044234#line-3","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5115.0,"shares_display":"5,115","price_per_share":82.92,"price_display":"82.92","price_state":"stated","total_value":424135.8,"total_display":"424,135.80","total_whole":"424,136","shares_owned_after":76976.0,"shares_owned_after_display":"76,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-31","filed_date":"2019-08-02","scope":"insider"},{"id":7927703,"accession":"0001209191-19-043642","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-043642","line_url":"/filing/0001209191-19-043642#line-7","is_derivative":false,"issuer_cik":"0001645113","issuer_name":"NovoCure Ltd","issuer_ticker":"NVCR","issuer_name_source":null,"issuer_url":"/issuer/0001645113","owner_cik":"0001744884","owner_name":"Shah Pritesh","owner_display_name":"Shah Pritesh","owner_url":"/insider/0001744884","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3857.0,"shares_display":"3,857","price_per_share":79.411,"price_display":"79.41","price_state":"stated","total_value":306288.227,"total_display":"306,288.23","total_whole":"306,288","shares_owned_after":77076.0,"shares_owned_after_display":"77,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-26","filed_date":"2019-07-30","scope":"insider"}],"collapsed":true,"next_cursor":"2019-07-26|7927703","ledger_fault":false,"count":{"value":79,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":78,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":79},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001645113","name":"NovoCure Ltd","url":"/issuer/0001645113","role":"Officer (Chief Growth Officer)","n_filings":45,"first_seen":"2018-12-13","last_seen":"2023-11-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001744884","retrieved_at":"2026-08-23T01:17:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}